Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-31 to 2023-06-22
Current total value of award: $3094.8
Description: 4561119898!XOLAIR 150 MG/ML SYRINGEML